| Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system CM Balch, SJ Soong, JE Gershenwald, JF Thompson, DS Reintgen, ... Journal of clinical oncology 19 (16), 3622-3634, 2001 | 2964 | 2001 |
| Development and validation of a predictive model for chemotherapy-associated thrombosis AA Khorana, NM Kuderer, E Culakova, GH Lyman, CW Francis Blood, The Journal of the American Society of Hematology 111 (10), 4902-4907, 2008 | 2390 | 2008 |
| American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer GH Lyman, AE Giuliano, MR Somerfield, AB Benson III, DC Bodurka, ... Journal of clinical oncology 23 (30), 7703-7720, 2005 | 2390 | 2005 |
| Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy AA Khorana, CW Francis, E Culakova, NM Kuderer, GH Lyman Journal of Thrombosis and Haemostasis 5 (3), 632-634, 2007 | 1917 | 2007 |
| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1862 | 2020 |
| Lymphatic mapping and sentinel node biopsy in the patient with breast cancer JJ Albertini, GH Lyman, C Cox, T Yeatman, L Balducci, NN Ku, S Shivers, ... Jama 276 (22), 1818-1822, 1996 | 1840 | 1996 |
| Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer J Crawford, H Ozer, R Stoller, D Johnson, G Lyman, I Tabbara, M Kris, ... New England Journal of Medicine 325 (3), 164-170, 1991 | 1789 | 1991 |
| American cancer society/American society of clinical oncology breast cancer survivorship care guideline CD Runowicz, CR Leach, NL Henry, KS Henry, HT Mackey, ... Journal of clinical oncology 34 (6), 611-635, 2016 | 1635 | 2016 |
| 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline TJ Smith, J Khatcheressian, GH Lyman, H Ozer, JO Armitage, L Balducci, ... Journal of Clinical Oncology 24 (19), 3187-3205, 2006 | 1596 | 2006 |
| Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients NM Kuderer, DC Dale, J Crawford, LE Cosler, GH Lyman Cancer 106 (10), 2258-2266, 2006 | 1426 | 2006 |
| Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update NS Key, AA Khorana, NM Kuderer, K Bohlke, AYY Lee, JI Arcelus, ... Journal of Clinical Oncology 38 (5), 496-520, 2020 | 1377 | 2020 |
| Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update GH Lyman, S Temin, SB Edge, LA Newman, RR Turner, DL Weaver, ... Journal of Clinical Oncology 32 (13), 1365-1383, 2014 | 1359 | 2014 |
| Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT-D) AM Young, A Marshall, J Thirlwall, O Chapman, A Lokare, C Hill, D Hale, ... Journal of Clinical Oncology 36 (20), 2017-2023, 2018 | 1354 | 2018 |
| American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer GH Lyman, AA Khorana, A Falanga, D Clarke-Pearson, C Flowers, ... Journal of clinical oncology 25 (34), 5490-5505, 2007 | 1329 | 2007 |
| Recommendations on the use of 18F-FDG PET in oncology JW Fletcher, B Djulbegovic, HP Soares, BA Siegel, VJ Lowe, GH Lyman, ... Journal of Nuclear Medicine 49 (3), 480-508, 2008 | 1327 | 2008 |
| 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with … MS Aapro, J Bohlius, DA Cameron, L Dal Lago, JP Donnelly, N Kearney, ... European journal of cancer 47 (1), 8-32, 2011 | 1252 | 2011 |
| Lymphatic mapping and sentinel lymph node biopsy in early‐stage breast carcinoma: a metaanalysis T Kim, AE Giuliano, GH Lyman Cancer 106 (1), 4-16, 2006 | 1213 | 2006 |
| Comorbidity and functional status are independent in older cancer patients. M Extermann, J Overcash, GH Lyman, J Parr, L Balducci Journal of Clinical Oncology 16 (4), 1582-1587, 1998 | 1190 | 1998 |
| Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High‐Age Patients (CRASH) score M Extermann, I Boler, RR Reich, GH Lyman, RH Brown, J DeFelice, ... Cancer 118 (13), 3377-3386, 2012 | 1171 | 2012 |
| Chemotherapy‐induced neutropenia: risks, consequences, and new directions for its management J Crawford, DC Dale, GH Lyman Cancer 100 (2), 228-237, 2004 | 1139 | 2004 |
Antonio C. Wolff, MD, FACP, FASCOProfessor of Oncology, Johns Hopkins University在 jhmi.edu 的电子邮件经过验证
